Karuna Therapeutics Investor Relations Material
Latest events
Q3 2023
Karuna Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Karuna Therapeutics Inc
Access all reports
Karuna Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for neurological and psychiatric disorders. The company's research focuses on discovering and utilizing novel pathways for medications that aim to significantly improve the lives of those affected by conditions such as schizophrenia and dementia-related psychosis. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Karuna Therapeutics Inc
Corporate Presentation
Karuna Therapeutics Inc
Corporate Presentation
Karuna Therapeutics Inc
Latest articles
Companies That Had Their IPO in 2019: Bull Market and Tech Dominance
Discussing the stock and IPO market in 2019, and the factors that led to the overall bullish performance of stocks during the year.
3 May 2024
Microsoft's Journey to Becoming the World's Most Valuable Company
Explore Microsoft's rise from a garage startup to the world's most valuable company, highlighting Bill Gates' role in shaping the digital revolution.
3 May 2024
Bill Gates: The Man Who Put a Computer in Every Home
Explore the life of Bill Gates, from co-founding Microsoft to global philanthropy, and his lasting impact on the world.
2 May 2024
Ticker symbol
Country
🇺🇸 United States